Search research articles
Contact Us
Filters
Showing results (11-20 of 23) with videos related to
Page
of 3
Sort By:
Medicine
|
December 15, 2015
125I Brachytherapy in Locally Advanced Nonsmall Cell Lung Cancer After Progression of Concurrent Radiochemotherapy
Zhanwang Xiang, Guohong Li, Zhenyin Liu, et al.
Quantitative Imaging in Medicine and Surgery
|
August 11, 2025
Donafenib <i>vs.</i> lenvatinib combined with transarterial chemoembolization as initial therapy for unresectable hepatocellular carcinoma: a retrospective real-world study
Huzheng Yan, Guohong Li, Chenghao Zhao, et al.
Oncotargets and Therapy
|
September 15, 2018
Zhanwang Xiang, Lifei Wang, Huzheng Yan, et al.
Oncotarget
|
February 27, 2016
125I brachytherapy in the palliation of painful bone metastases from lung cancer after failure or rejection of conventional treatments
Zhanwang Xiang, Zhiqiang Mo, Guohong Li, et al.
European Radiology
|
September 29, 2017
Feasibility and clinical value of CT-guided <sup>125</sup>I brachytherapy for metastatic soft tissue sarcoma after first-line chemotherapy failure
Zhiqiang Mo, Tao Zhang, Yanling Zhang, et al.
Translational Oncology
|
December 20, 2016
CT-guided <sup>125</sup>I brachytherapy in the treatment of distant metastases in the oral cavity and maxillofacial region
Huzheng Yan, Zhanwang Xiang, Zhihui Zhong, et al.
Academic Radiology
|
May 17, 2024
Transarterial Chemoembolization (TACE) Combined with Lenvatinib versus TACE Alone in Intermediate-Stage Hepatocellular Carcinoma Patients Beyond Up-To-Seven Criteria: A Retrospective, Propensity Score-Matched Analysis
Churen Zhou, Boyang Chang, Zhanwang Xiang, et al.
Quantitative Imaging in Medicine and Surgery
|
January 12, 2026
Lenvatinib continuation versus regorafenib in treating hepatocellular carcinoma after lenvatinib failure
Tao Pan, Chenghao Zhao, Luwen Mu, et al.
Journal of Cancer Research and Clinical Oncology
|
June 5, 2019
Safety and efficacy of <sup>125</sup>I brachytherapy for bilateral lung recurrences from hepatocellular carcinoma after resection or ablation
Zhanwang Xiang, Mingjun Bai, Guohong Li, et al.
Journal of Cancer
|
August 19, 2017
CT-guided <sup>125</sup>I brachytherapy for locally recurrent nasopharyngeal carcinoma
Huzheng Yan, Zhiqiang Mo, Zhanwang Xiang, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 23) with videos related to
Sort By:
Page
of 3
Medicine
|
December 15, 2015
125I Brachytherapy in Locally Advanced Nonsmall Cell Lung Cancer After Progression of Concurrent Radiochemotherapy
Zhanwang Xiang, Guohong Li, Zhenyin Liu, et al.
Quantitative Imaging in Medicine and Surgery
|
August 11, 2025
Donafenib <i>vs.</i> lenvatinib combined with transarterial chemoembolization as initial therapy for unresectable hepatocellular carcinoma: a retrospective real-world study
Huzheng Yan, Guohong Li, Chenghao Zhao, et al.
Oncotargets and Therapy
|
September 15, 2018
Zhanwang Xiang, Lifei Wang, Huzheng Yan, et al.
Oncotarget
|
February 27, 2016
125I brachytherapy in the palliation of painful bone metastases from lung cancer after failure or rejection of conventional treatments
Zhanwang Xiang, Zhiqiang Mo, Guohong Li, et al.
European Radiology
|
September 29, 2017
Feasibility and clinical value of CT-guided <sup>125</sup>I brachytherapy for metastatic soft tissue sarcoma after first-line chemotherapy failure
Zhiqiang Mo, Tao Zhang, Yanling Zhang, et al.
Translational Oncology
|
December 20, 2016
CT-guided <sup>125</sup>I brachytherapy in the treatment of distant metastases in the oral cavity and maxillofacial region
Huzheng Yan, Zhanwang Xiang, Zhihui Zhong, et al.
Academic Radiology
|
May 17, 2024
Transarterial Chemoembolization (TACE) Combined with Lenvatinib versus TACE Alone in Intermediate-Stage Hepatocellular Carcinoma Patients Beyond Up-To-Seven Criteria: A Retrospective, Propensity Score-Matched Analysis
Churen Zhou, Boyang Chang, Zhanwang Xiang, et al.
Quantitative Imaging in Medicine and Surgery
|
January 12, 2026
Lenvatinib continuation versus regorafenib in treating hepatocellular carcinoma after lenvatinib failure
Tao Pan, Chenghao Zhao, Luwen Mu, et al.
Journal of Cancer Research and Clinical Oncology
|
June 5, 2019
Safety and efficacy of <sup>125</sup>I brachytherapy for bilateral lung recurrences from hepatocellular carcinoma after resection or ablation
Zhanwang Xiang, Mingjun Bai, Guohong Li, et al.
Journal of Cancer
|
August 19, 2017
CT-guided <sup>125</sup>I brachytherapy for locally recurrent nasopharyngeal carcinoma
Huzheng Yan, Zhiqiang Mo, Zhanwang Xiang, et al.
Page
of 3